Dr. Scott Schuetze, MD, PhD
Claim this profileUniversity of Michigan
Studies Liposarcoma
Studies Sarcoma
8 reported clinical trials
11 drugs studied
Area of expertise
1Liposarcoma
Stage IV
Stage III
MDM2 positive
2Sarcoma
Stage IV
Stage III
FGFR positive
Affiliated Hospitals
Clinical Trials Scott Schuetze, MD, PhD is currently running
CDK4/6 Inhibitor
for Liposarcoma
This trial tests SPH4336, a chemotherapy pill, in patients with CDK4-positive liposarcomas. The drug works by blocking an enzyme that cancer cells need to grow, aiming to stop tumor growth.
Recruiting1 award Phase 2
Afamitresgene Autoleucel
for Sarcoma
This is a study to investigate the efficacy and safety of ADP-A2M4 in HLA-A\*02 eligible and MAGE-A4 positive subjects with metastatic or inoperable (advanced) Synovial Sarcoma (Cohort 1, 2 and 3 ) or MRCLS (Cohort 1) .
Recruiting1 award Phase 29 criteria
More about Scott Schuetze, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Scott Schuetze, MD, PhD has experience with
- Nivolumab
- BI 907828
- Doxorubicin
- Regorafenib
- SPH4336
- Paclitaxel
Breakdown of trials Scott Schuetze, MD, PhD has run
Liposarcoma
Sarcoma
Osteosarcoma
Visceral Angiosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Schuetze, MD, PhD specialize in?
Scott Schuetze, MD, PhD focuses on Liposarcoma and Sarcoma. In particular, much of their work with Liposarcoma has involved Stage IV patients, or patients who are Stage III.
Is Scott Schuetze, MD, PhD currently recruiting for clinical trials?
Yes, Scott Schuetze, MD, PhD is currently recruiting for 4 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Scott Schuetze, MD, PhD has studied deeply?
Yes, Scott Schuetze, MD, PhD has studied treatments such as Nivolumab, BI 907828, Doxorubicin.
What is the best way to schedule an appointment with Scott Schuetze, MD, PhD?
Apply for one of the trials that Scott Schuetze, MD, PhD is conducting.
What is the office address of Scott Schuetze, MD, PhD?
The office of Scott Schuetze, MD, PhD is located at: University of Michigan, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.